Janssen Pharmaceutica Nv

Alexander Valdes

Steven D Goldberg

Steven P Meduna

Stefan McCarver

Xiaohua Xue

Steven Loskot

Douglas Behenna

Timothy B Rhorer

Connor L Martin

John M Keith

Craig R Woods

Alexander Raymond Rovira

Deane Gordon

Luke E Hanna

David A Kummer

Jennifer Diane Venable

Brock T Shireman

Dongpei Wu

Virginia M Tanis

Charlotte Pooley Deckhut

Dougas C Behenna

Kristen Song

Alexander Rovira

The present application discloses compounds having the following formula: or pharmaceutically acceptable salts thereof, wherein R, R, R, and Rare defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediated syndrome, disorder and/or disease.

Imidazopyridazine IL-17 inhibitor compounds

The present application discloses compounds having the following formula: or pharmaceutically acceptable salts thereof, wherein R, R, R, Rand Rare defined in the specification, as well as methods of making and using the compounds disclosed herein for treating or ameliorating an IL-17 mediated syndrome, disorder and/or disease.

Imidazopyridazines as modulators of IL-17

Growing community of inventors

San Diego, CA, United States of America

Alexander Valdes